History

Establishing leadership through innovation

AngioDynamics’ history is best characterized by innovation and growth. The company was founded in Queensbury in 1988 and has grown into a NASDAQ-listed public company with a total market capitalization of more than $400 million.

AngioDynamics’ president and CEO Eamonn Hobbs co-founded the Company in 1988 in Queensbury, New York. Queensbury was chosen due to its location in the heart of “Catheter Valley,” an area in New York’s Adirondack Region named for its long history of catheter and other medical device manufacturing.

Initially dedicated to the research and development of products used in interventional radiology, AngioDynamics began shipping product in the early 1990s. The Company soon became well established as a producer of diagnostic catheters for non-coronary angiography and thrombolytic delivery systems. In May 2004 the Company became publicly traded on the NASDAQ stock exchange as ANGO.

Another landmark event occurred in January 2007, when the Company acquired RITA Medical Systems, a respected provider of medical oncology devices. The acquisition, which included facilities in California and Georgia and increased its number of total employees by about 200 to nearly 550, gave AngioDynamics immediate access to the burgeoning interventional oncology market through RITA’s specialized sales force.

With the addition of RITA’s complementary products to its existing market basket, AngioDynamics now boasts a diverse product line that includes radiofrequency ablation systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products.